Rethinking Psychiatric Drugs: A Guide for Informed Consent-- Are patients aware of the fact that pharmacological therapies stress the brain in ways which may prevent or postpone symptomatic and functional recovery ? ==================================================== Rethinking Psychiatric Drugs: A Guide for Informed Consent is a critical appraisal of the medications which an estimated 20% of Americans consume on a regular (and sometimes involuntary) basis. It is the philosophically, epidemiologically, and scientifically supported revelation of how and why psychiatry’s drug therapies have contributed to a standard of care which frequently does more to harm than to cure. Extensively researched and documented, the book addresses: -- the process by which psychiatric drugs reach the market -- the common flaws in research methodologies which negate the validity of the psychiatric RCT (Randomized Controlled Trial) -- the problem of allostatic load (how drugs stress the body) -- the history, long term effects, and utility of the drugs used to suppress symptoms of depression, psychosis, inattention and hyperactivity -- the effectiveness of alternatives to medication Rethinking Psychiatric Drugs: A Guide for Informed Consent exposes the current crisis in medical ethics and epistemology, and attempts to restore to psychiatry an authentically informed consent to care.
|
What people are saying - Write a review
References to this book
Bibliographic information
| Title | Rethinking Psychiatric Drugs: A Guide for Informed Consent |
| Author | Grace E. Jackson |
| Edition | illustrated |
| Publisher | AuthorHouse, 2005 |
| ISBN | 1420867415, 9781420867411 |
| Length | 420 pages |
| Export Citation | BiBTeX EndNote RefMan |